Intrinsic Value

The intrinsic value of Castle Biosciences Inc (CSTL) under the Base Case is USD per share. Compared with the current market price of 33.79 USD, the stock appears .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

CSTL Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when CSTL is below its intrinsic value
Today Hidden ·
CSTL Valuation History

Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.

Create a free account · No card needed

Alternatives to CSTL

Fundamental Analysis

What Castle Biosciences Does

Health Care

Castle Biosciences makes laboratory tests that help doctors make treatment decisions for cancers and other skin-related conditions. Its best-known products are molecular diagnostic tests, including tests for melanoma and other skin cancers, that analyze tissue samples and give doctors more information about how aggressive a disease may be and how a patient may respond to treatment.

Headquarters
United States of America US
Employees
883
IPO date
Jul 25, 2019
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Castle Biosciences Inc

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

CSTL Insider Trading
Buy and sell transactions by insiders

Continue CSTL Research

Decided on Castle Biosciences? Get an email when CSTL reaches the price you’d buy at. Free with an account.

Other Castle Biosciences listings

What is the Intrinsic Value of one CSTL stock?

The intrinsic value for Castle Biosciences Inc (CSTL) under the Base Case is USD.

Is CSTL stock undervalued or overvalued?

Compared with the current market price of 33.79 USD, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top